XTRA:RDCConsumer Retailing
Redcare Pharmacy (XTRA:RDC) Valuation Check After First Quarter 2026 Revenue And Earnings Update
Redcare Pharmacy (XTRA:RDC) drew investor attention after reporting first quarter 2026 results, with sales of €849.5 million versus €717.3 million a year earlier and a net loss of €10.5 million versus €10.8 million.
See our latest analysis for Redcare Pharmacy.
The latest first quarter results appear to have reset sentiment in the short term, with the share price up 6.93% over one day and 19.05% over 30 days. However, the year to date share price return of 28.48% and 1 year total shareholder...